Uptravi 1600 MCG tab - anchorage VAMC

Ended Awarded Last action

Contract number
36C26023F0409
Awardee
Awarding agency
Obligated
$178,065

Award facts

Contract value 100% obligated
$178,064.76 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Titusville, Hopewell Township, NJ 08560, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $3,050
Original award $175,014

About this award

This is a delivery order award to Actelion Pharmaceuticals US, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract with the Department of Veterans Affairs (VA). The award, valued at $178,064.76, is for the supply of Uptravi 1600 mcg tablets to the Anchorage VA Medical Center. Uptravi is a medication used to treat pulmonary arterial hypertension, a condition common among veterans. Actelion Pharmaceuticals is a large, for-profit pharmaceutical manufacturer that specializes in treatments for rare diseases, including pulmonary hypertension. The company holds several significant Indefinite Delivery Vehicle (IDV) contracts with the federal government, including a $105 million, five-year Federal Supply Schedule contract and a $60 million Blanket Purchase Agreement (BPA) specifically for pulmonary arterial hypertension therapies. This delivery order is not designated as a small business set-aside.

Quick answers

Who was awarded contract 36C26023F0409?

36C26023F0409 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on July 21, 2023.

How much is contract 36C26023F0409 worth?

The government has obligated $178,065 on 36C26023F0409.

Is contract 36C26023F0409 an order under another contract?

Yes. 36C26023F0409 is a delivery order under 36F79719D0142, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26023F0409 competed?

The extent of competition for 36C26023F0409 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award